EyePoint Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
EyePoint Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker EYPT.
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone...
Can you invest in EyePoint Pharmaceuticals, Inc.?
Yes. EyePoint Pharmaceuticals, Inc. trades publicly on NASDAQ as EYPT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for EyePoint Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.